Determination of personalized diabetes treatment plans using a two-delay model

Diabetes cases worldwide have risen steadily over the past few decades, lending urgency to the search for more efficient, effective, and personalized ways to treat the disease. Current treatment strategies, however, may fail to maintain oscillations in blood glucose concentration that naturally occu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of theoretical biology 2014-10, Vol.359, p.101-111
Hauptverfasser: Kissler, S.M., Cichowitz, C., Sankaranarayanan, S., Bortz, D.M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 111
container_issue
container_start_page 101
container_title Journal of theoretical biology
container_volume 359
creator Kissler, S.M.
Cichowitz, C.
Sankaranarayanan, S.
Bortz, D.M.
description Diabetes cases worldwide have risen steadily over the past few decades, lending urgency to the search for more efficient, effective, and personalized ways to treat the disease. Current treatment strategies, however, may fail to maintain oscillations in blood glucose concentration that naturally occur multiple times per day, an important element of normal human physiology. Building upon recent successes in mathematical modeling of the human glucose–insulin system, we show that both food intake and insulin therapy likely demand increasingly precise control over insulin sensitivity if oscillations at a healthy average glucose concentration are to be maintained. We then model and describe personalized treatment options for patients with diabetes that maintain these oscillations. We predict that for a person with type II diabetes, both blood glucose levels can be controlled and healthy oscillations maintained when the patient gets an hour of daily exercise and is placed on a combination of Metformin and sulfonylurea drugs. We note that insulin therapy and an additional hour of exercise will reduce the patient׳s need for sulfonylureas. Results of a modeling analysis suggest that, with constant nutrition and controlled exercise, the blood glucose levels of a person with type I diabetes can be properly controlled with insulin infusion between 0.45 and 0.7μU/mlmin. Lastly, we note that all suggested strategies rely on existing clinical techniques and established treatment measures, and so could potentially be of immediate use in the design of an artificial pancreas. •We use a two-delay model to investigate personalized treatment options for diabetes.•The model describes maintenance of T2D oscillations with exercise and medication.•Insulin therapy and an additional hour of exercise reduces need for sulfonylureas.•These strategies could be of immediate use in the design of an artificial pancreas.
doi_str_mv 10.1016/j.jtbi.2014.06.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1554474393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022519314003427</els_id><sourcerecordid>1554474393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-a60a273a02d7427b031a22286b8b3dcdbc3347b8ce3ea2b72000736934d57d33</originalsourceid><addsrcrecordid>eNp9kDtPIzEUhS0EIlngD1AglzQzXD9mnJFoEAu7SAia9JYfN8jRzDjYDgh-_U4UlpLqNt85Ovcj5JxBzYC1V-t6XWyoOTBZQ1sDNAdkzqBrqkUj2SGZA3BeNawTM_Ir5zUAdFK0x2TGZSdYq8ScPP3GgmkIoykhjjSu6AZTjqPpwyd66oOxE5BpSWjKgGOhm96MmW5zGF-ooeU9Vh5780GHON1TcrQyfcazr3tClvd3y9u_1ePzn4fbm8fKSYBSmRYMV8IA90pyZUEwwzlftHZhhXfeOiGksguHAg23ik_TlWg7IX2jvBAn5HJfu0nxdYu56CFkh_00DeM2a9Y0Uiopuh3K96hLMeeEK71JYTDpQzPQO416rXca9U6jhlZPGqfQxVf_1g7ovyP_vU3A9R7A6cm3gElnF3B06ENCV7SP4af-f-K1g24</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1554474393</pqid></control><display><type>article</type><title>Determination of personalized diabetes treatment plans using a two-delay model</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kissler, S.M. ; Cichowitz, C. ; Sankaranarayanan, S. ; Bortz, D.M.</creator><creatorcontrib>Kissler, S.M. ; Cichowitz, C. ; Sankaranarayanan, S. ; Bortz, D.M.</creatorcontrib><description>Diabetes cases worldwide have risen steadily over the past few decades, lending urgency to the search for more efficient, effective, and personalized ways to treat the disease. Current treatment strategies, however, may fail to maintain oscillations in blood glucose concentration that naturally occur multiple times per day, an important element of normal human physiology. Building upon recent successes in mathematical modeling of the human glucose–insulin system, we show that both food intake and insulin therapy likely demand increasingly precise control over insulin sensitivity if oscillations at a healthy average glucose concentration are to be maintained. We then model and describe personalized treatment options for patients with diabetes that maintain these oscillations. We predict that for a person with type II diabetes, both blood glucose levels can be controlled and healthy oscillations maintained when the patient gets an hour of daily exercise and is placed on a combination of Metformin and sulfonylurea drugs. We note that insulin therapy and an additional hour of exercise will reduce the patient׳s need for sulfonylureas. Results of a modeling analysis suggest that, with constant nutrition and controlled exercise, the blood glucose levels of a person with type I diabetes can be properly controlled with insulin infusion between 0.45 and 0.7μU/mlmin. Lastly, we note that all suggested strategies rely on existing clinical techniques and established treatment measures, and so could potentially be of immediate use in the design of an artificial pancreas. •We use a two-delay model to investigate personalized treatment options for diabetes.•The model describes maintenance of T2D oscillations with exercise and medication.•Insulin therapy and an additional hour of exercise reduces need for sulfonylureas.•These strategies could be of immediate use in the design of an artificial pancreas.</description><identifier>ISSN: 0022-5193</identifier><identifier>EISSN: 1095-8541</identifier><identifier>DOI: 10.1016/j.jtbi.2014.06.005</identifier><identifier>PMID: 24931673</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Artificial pancreas ; Biological Clocks - physiology ; Blood glucose ; Blood Glucose - metabolism ; Diabetes Mellitus - blood ; Diabetes Mellitus - drug therapy ; Humans ; Insulin - administration &amp; dosage ; Insulin - blood ; Insulin sensitivity ; Metformin - administration &amp; dosage ; Patient-Specific Modeling ; Personalized medicine ; Precision Medicine - methods ; Sulfonylurea Compounds - administration &amp; dosage ; Time Factors ; Ultradian oscillations</subject><ispartof>Journal of theoretical biology, 2014-10, Vol.359, p.101-111</ispartof><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-a60a273a02d7427b031a22286b8b3dcdbc3347b8ce3ea2b72000736934d57d33</citedby><cites>FETCH-LOGICAL-c400t-a60a273a02d7427b031a22286b8b3dcdbc3347b8ce3ea2b72000736934d57d33</cites><orcidid>0000-0001-6000-8387 ; 0000-0003-1163-7317</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jtbi.2014.06.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24931673$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kissler, S.M.</creatorcontrib><creatorcontrib>Cichowitz, C.</creatorcontrib><creatorcontrib>Sankaranarayanan, S.</creatorcontrib><creatorcontrib>Bortz, D.M.</creatorcontrib><title>Determination of personalized diabetes treatment plans using a two-delay model</title><title>Journal of theoretical biology</title><addtitle>J Theor Biol</addtitle><description>Diabetes cases worldwide have risen steadily over the past few decades, lending urgency to the search for more efficient, effective, and personalized ways to treat the disease. Current treatment strategies, however, may fail to maintain oscillations in blood glucose concentration that naturally occur multiple times per day, an important element of normal human physiology. Building upon recent successes in mathematical modeling of the human glucose–insulin system, we show that both food intake and insulin therapy likely demand increasingly precise control over insulin sensitivity if oscillations at a healthy average glucose concentration are to be maintained. We then model and describe personalized treatment options for patients with diabetes that maintain these oscillations. We predict that for a person with type II diabetes, both blood glucose levels can be controlled and healthy oscillations maintained when the patient gets an hour of daily exercise and is placed on a combination of Metformin and sulfonylurea drugs. We note that insulin therapy and an additional hour of exercise will reduce the patient׳s need for sulfonylureas. Results of a modeling analysis suggest that, with constant nutrition and controlled exercise, the blood glucose levels of a person with type I diabetes can be properly controlled with insulin infusion between 0.45 and 0.7μU/mlmin. Lastly, we note that all suggested strategies rely on existing clinical techniques and established treatment measures, and so could potentially be of immediate use in the design of an artificial pancreas. •We use a two-delay model to investigate personalized treatment options for diabetes.•The model describes maintenance of T2D oscillations with exercise and medication.•Insulin therapy and an additional hour of exercise reduces need for sulfonylureas.•These strategies could be of immediate use in the design of an artificial pancreas.</description><subject>Artificial pancreas</subject><subject>Biological Clocks - physiology</subject><subject>Blood glucose</subject><subject>Blood Glucose - metabolism</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - drug therapy</subject><subject>Humans</subject><subject>Insulin - administration &amp; dosage</subject><subject>Insulin - blood</subject><subject>Insulin sensitivity</subject><subject>Metformin - administration &amp; dosage</subject><subject>Patient-Specific Modeling</subject><subject>Personalized medicine</subject><subject>Precision Medicine - methods</subject><subject>Sulfonylurea Compounds - administration &amp; dosage</subject><subject>Time Factors</subject><subject>Ultradian oscillations</subject><issn>0022-5193</issn><issn>1095-8541</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtPIzEUhS0EIlngD1AglzQzXD9mnJFoEAu7SAia9JYfN8jRzDjYDgh-_U4UlpLqNt85Ovcj5JxBzYC1V-t6XWyoOTBZQ1sDNAdkzqBrqkUj2SGZA3BeNawTM_Ir5zUAdFK0x2TGZSdYq8ScPP3GgmkIoykhjjSu6AZTjqPpwyd66oOxE5BpSWjKgGOhm96MmW5zGF-ooeU9Vh5780GHON1TcrQyfcazr3tClvd3y9u_1ePzn4fbm8fKSYBSmRYMV8IA90pyZUEwwzlftHZhhXfeOiGksguHAg23ik_TlWg7IX2jvBAn5HJfu0nxdYu56CFkh_00DeM2a9Y0Uiopuh3K96hLMeeEK71JYTDpQzPQO416rXca9U6jhlZPGqfQxVf_1g7ovyP_vU3A9R7A6cm3gElnF3B06ENCV7SP4af-f-K1g24</recordid><startdate>20141021</startdate><enddate>20141021</enddate><creator>Kissler, S.M.</creator><creator>Cichowitz, C.</creator><creator>Sankaranarayanan, S.</creator><creator>Bortz, D.M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6000-8387</orcidid><orcidid>https://orcid.org/0000-0003-1163-7317</orcidid></search><sort><creationdate>20141021</creationdate><title>Determination of personalized diabetes treatment plans using a two-delay model</title><author>Kissler, S.M. ; Cichowitz, C. ; Sankaranarayanan, S. ; Bortz, D.M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-a60a273a02d7427b031a22286b8b3dcdbc3347b8ce3ea2b72000736934d57d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Artificial pancreas</topic><topic>Biological Clocks - physiology</topic><topic>Blood glucose</topic><topic>Blood Glucose - metabolism</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - drug therapy</topic><topic>Humans</topic><topic>Insulin - administration &amp; dosage</topic><topic>Insulin - blood</topic><topic>Insulin sensitivity</topic><topic>Metformin - administration &amp; dosage</topic><topic>Patient-Specific Modeling</topic><topic>Personalized medicine</topic><topic>Precision Medicine - methods</topic><topic>Sulfonylurea Compounds - administration &amp; dosage</topic><topic>Time Factors</topic><topic>Ultradian oscillations</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kissler, S.M.</creatorcontrib><creatorcontrib>Cichowitz, C.</creatorcontrib><creatorcontrib>Sankaranarayanan, S.</creatorcontrib><creatorcontrib>Bortz, D.M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of theoretical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kissler, S.M.</au><au>Cichowitz, C.</au><au>Sankaranarayanan, S.</au><au>Bortz, D.M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of personalized diabetes treatment plans using a two-delay model</atitle><jtitle>Journal of theoretical biology</jtitle><addtitle>J Theor Biol</addtitle><date>2014-10-21</date><risdate>2014</risdate><volume>359</volume><spage>101</spage><epage>111</epage><pages>101-111</pages><issn>0022-5193</issn><eissn>1095-8541</eissn><abstract>Diabetes cases worldwide have risen steadily over the past few decades, lending urgency to the search for more efficient, effective, and personalized ways to treat the disease. Current treatment strategies, however, may fail to maintain oscillations in blood glucose concentration that naturally occur multiple times per day, an important element of normal human physiology. Building upon recent successes in mathematical modeling of the human glucose–insulin system, we show that both food intake and insulin therapy likely demand increasingly precise control over insulin sensitivity if oscillations at a healthy average glucose concentration are to be maintained. We then model and describe personalized treatment options for patients with diabetes that maintain these oscillations. We predict that for a person with type II diabetes, both blood glucose levels can be controlled and healthy oscillations maintained when the patient gets an hour of daily exercise and is placed on a combination of Metformin and sulfonylurea drugs. We note that insulin therapy and an additional hour of exercise will reduce the patient׳s need for sulfonylureas. Results of a modeling analysis suggest that, with constant nutrition and controlled exercise, the blood glucose levels of a person with type I diabetes can be properly controlled with insulin infusion between 0.45 and 0.7μU/mlmin. Lastly, we note that all suggested strategies rely on existing clinical techniques and established treatment measures, and so could potentially be of immediate use in the design of an artificial pancreas. •We use a two-delay model to investigate personalized treatment options for diabetes.•The model describes maintenance of T2D oscillations with exercise and medication.•Insulin therapy and an additional hour of exercise reduces need for sulfonylureas.•These strategies could be of immediate use in the design of an artificial pancreas.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24931673</pmid><doi>10.1016/j.jtbi.2014.06.005</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6000-8387</orcidid><orcidid>https://orcid.org/0000-0003-1163-7317</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-5193
ispartof Journal of theoretical biology, 2014-10, Vol.359, p.101-111
issn 0022-5193
1095-8541
language eng
recordid cdi_proquest_miscellaneous_1554474393
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Artificial pancreas
Biological Clocks - physiology
Blood glucose
Blood Glucose - metabolism
Diabetes Mellitus - blood
Diabetes Mellitus - drug therapy
Humans
Insulin - administration & dosage
Insulin - blood
Insulin sensitivity
Metformin - administration & dosage
Patient-Specific Modeling
Personalized medicine
Precision Medicine - methods
Sulfonylurea Compounds - administration & dosage
Time Factors
Ultradian oscillations
title Determination of personalized diabetes treatment plans using a two-delay model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T05%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20personalized%20diabetes%20treatment%20plans%20using%20a%20two-delay%20model&rft.jtitle=Journal%20of%20theoretical%20biology&rft.au=Kissler,%20S.M.&rft.date=2014-10-21&rft.volume=359&rft.spage=101&rft.epage=111&rft.pages=101-111&rft.issn=0022-5193&rft.eissn=1095-8541&rft_id=info:doi/10.1016/j.jtbi.2014.06.005&rft_dat=%3Cproquest_cross%3E1554474393%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1554474393&rft_id=info:pmid/24931673&rft_els_id=S0022519314003427&rfr_iscdi=true